China Injectable Anticoagulants Market Report & Forecast 2021-2027

Publisher Name :
Date: 24-Aug-2021
No. of pages: 90
Inquire Before Buying

This report contains market size and forecasts of Injectable Anticoagulants in China, including the following market information:

China Injectable Anticoagulants Market Revenue, 2016-2021, 2022-2027, ($ millions)

China top five Injectable Anticoagulants companies in 2020 (%)

The global Injectable Anticoagulants market size is expected to growth from US$ 5945 million in 2020 to US$ 6901 million by 2027; it is expected to grow at a CAGR of 2.1% during 2021-2027.

The China Injectable Anticoagulants market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.

QYResearch has surveyed the Injectable Anticoagulants Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

China Injectable Anticoagulants Market, By Type, 2016-2021, 2022-2027 ($ Millions)

China Injectable Anticoagulants Market Segment Percentages, By Type, 2020 (%)

- Low-Molecular-Weight Heparin (LMWH)

- Direct Thrombin Inhibitor (DTI)

- Others

China Injectable Anticoagulants Market, By Application, 2016-2021, 2022-2027 ($ Millions)

China Injectable Anticoagulants Market Segment Percentages, By Application, 2020 (%)

- VTE

- ACS/MI

- AF

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Injectable Anticoagulants revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Injectable Anticoagulants revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Sanofi

- Genentech (Roche)

- Boehringer Ingelheim

- Pfizer

- The Medicines Company

- Aspen

- Otsuka

China Injectable Anticoagulants Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Injectable Anticoagulants Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Injectable Anticoagulants Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Injectable Anticoagulants Overall Market Size
2.1 China Injectable Anticoagulants Market Size: 2021 VS 2027
2.2 China Injectable Anticoagulants Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Injectable Anticoagulants Players in China Market
3.2 Top China Injectable Anticoagulants Companies Ranked by Revenue
3.3 China Injectable Anticoagulants Revenue by Companies
3.4 Top 3 and Top 5 Injectable Anticoagulants Companies in China Market, by Revenue in 2020
3.5 Companies Injectable Anticoagulants Product Type
3.6 Tier 1, Tier 2 and Tier 3 Injectable Anticoagulants Players in China Market
3.6.1 List of Tier 1 Injectable Anticoagulants Companies in China
3.6.2 List of Tier 2 and Tier 3 Injectable Anticoagulants Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Injectable Anticoagulants Market Size Markets, 2021 & 2027
4.1.2 Low-Molecular-Weight Heparin (LMWH)
4.1.3 Direct Thrombin Inhibitor (DTI)
4.1.4 Others
4.2 By Type - China Injectable Anticoagulants Revenue & Forecasts
4.2.1 By Type - China Injectable Anticoagulants Revenue, 2016-2021
4.2.2 By Type - China Injectable Anticoagulants Revenue, 2022-2027
4.2.3 By Type - China Injectable Anticoagulants Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Injectable Anticoagulants Market Size, 2021 & 2027
5.1.2 VTE
5.1.3 ACS/MI
5.1.4 AF
5.1.5 Others
5.2 By Application - China Injectable Anticoagulants Revenue & Forecasts
5.2.1 By Application - China Injectable Anticoagulants Revenue, 2016-2021
5.2.2 By Application - China Injectable Anticoagulants Revenue, 2022-2027
5.2.3 By Application - China Injectable Anticoagulants Revenue Market Share, 2016-2027
6 Injectable Anticoagulants Companies Profiles
6.1 Sanofi
6.1.1 Sanofi Company Details
6.1.2 Sanofi Business Overview
6.1.3 Sanofi Injectable Anticoagulants Introduction
6.1.4 Sanofi Injectable Anticoagulants Revenue in China Market (2016-2021)
6.1.5 Sanofi Recent Developments
6.2 Genentech (Roche)
6.2.1 Genentech (Roche) Company Details
6.2.2 Genentech (Roche) Business Overview
6.2.3 Genentech (Roche) Injectable Anticoagulants Introduction
6.2.4 Genentech (Roche) Injectable Anticoagulants Revenue in China Market (2016-2021)
6.2.5 Genentech (Roche) Recent Developments
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Details
6.3.2 Boehringer Ingelheim Business Overview
6.3.3 Boehringer Ingelheim Injectable Anticoagulants Introduction
6.3.4 Boehringer Ingelheim Injectable Anticoagulants Revenue in China Market (2016-2021)
6.3.5 Boehringer Ingelheim Recent Developments
6.4 Pfizer
6.4.1 Pfizer Company Details
6.4.2 Pfizer Business Overview
6.4.3 Pfizer Injectable Anticoagulants Introduction
6.4.4 Pfizer Injectable Anticoagulants Revenue in China Market (2016-2021)
6.4.5 Pfizer Recent Developments
6.5 The Medicines Company
6.5.1 The Medicines Company Company Details
6.5.2 The Medicines Company Business Overview
6.5.3 The Medicines Company Injectable Anticoagulants Introduction
6.5.4 The Medicines Company Injectable Anticoagulants Revenue in China Market (2016-2021)
6.5.5 The Medicines Company Recent Developments
6.6 Aspen
6.6.1 Aspen Company Details
6.6.2 Aspen Business Overview
6.6.3 Aspen Injectable Anticoagulants Introduction
6.6.4 Aspen Injectable Anticoagulants Revenue in China Market (2016-2021)
6.6.5 Aspen Recent Developments
6.7 Otsuka
6.7.1 Otsuka Company Details
6.7.2 Otsuka Business Overview
6.7.3 Otsuka Injectable Anticoagulants Introduction
6.7.4 Otsuka Injectable Anticoagulants Revenue in China Market (2016-2021)
6.7.5 Otsuka Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Injectable Anticoagulants Market Opportunities & Trends in China Market
Table 2. Injectable Anticoagulants Market Drivers in China Market
Table 3. Injectable Anticoagulants Market Restraints in China Market
Table 4. Key Players of Injectable Anticoagulants in China Market
Table 5. Top Injectable Anticoagulants Players in China Market, Ranking by Revenue (2019)
Table 6. China Injectable Anticoagulants Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Injectable Anticoagulants Revenue Share by Companies, 2016-2021
Table 8. Companies Injectable Anticoagulants Product Type
Table 9. List of Tier 1 Injectable Anticoagulants Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Injectable Anticoagulants Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Injectable Anticoagulants Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Injectable Anticoagulants Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Injectable Anticoagulants Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Injectable Anticoagulants Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Injectable Anticoagulants Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Injectable Anticoagulants Revenue (US$, Mn), 2022-2027
Table 17. Sanofi Company Details
Table 18. Sanofi Business Overview
Table 19. Sanofi Injectable Anticoagulants Product
Table 20. Sanofi Injectable Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Sanofi Recent Developments
Table 22. Genentech (Roche) Company Details
Table 23. Genentech (Roche) Business Overview
Table 24. Genentech (Roche) Injectable Anticoagulants Product
Table 25. Genentech (Roche) Injectable Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Genentech (Roche) Recent Developments
Table 27. Boehringer Ingelheim Company Details
Table 28. Boehringer Ingelheim Business Overview
Table 29. Boehringer Ingelheim Injectable Anticoagulants Product
Table 30. Boehringer Ingelheim Injectable Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Boehringer Ingelheim Recent Developments
Table 32. Pfizer Company Details
Table 33. Pfizer Business Overview
Table 34. Pfizer Injectable Anticoagulants Product
Table 35. Pfizer Injectable Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Pfizer Recent Developments
Table 37. The Medicines Company Company Details
Table 38. The Medicines Company Business Overview
Table 39. The Medicines Company Injectable Anticoagulants Product
Table 40. The Medicines Company Injectable Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 41. The Medicines Company Recent Developments
Table 42. Aspen Company Details
Table 43. Aspen Business Overview
Table 44. Aspen Injectable Anticoagulants Product
Table 45. Aspen Injectable Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Aspen Recent Developments
Table 47. Otsuka Company Details
Table 48. Otsuka Business Overview
Table 49. Otsuka Injectable Anticoagulants Product
Table 50. Otsuka Injectable Anticoagulants Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Otsuka Recent Developments
List of Figures
Figure 1. Injectable Anticoagulants Segment by Type
Figure 2. Injectable Anticoagulants Segment by Application
Figure 3. China Injectable Anticoagulants Market Overview: 2020
Figure 4. China Injectable Anticoagulants Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Injectable Anticoagulants Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Injectable Anticoagulants Revenue in 2020
Figure 7. By Type - China Injectable Anticoagulants Revenue Market Share, 2016-2027
Figure 8. By Application - China Injectable Anticoagulants Revenue Market Share, 2016-2027
Figure 9. Sanofi Injectable Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Genentech (Roche) Injectable Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Boehringer Ingelheim Injectable Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Pfizer Injectable Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. The Medicines Company Injectable Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Aspen Injectable Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Otsuka Injectable Anticoagulants Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Fibrinogen Concentrate Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......
  • Global Fibrinogen Concentrate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91
    According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......
  • Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124
    Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......
  • Global Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......
  • Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......
  • Global Low Molecular Weight Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......
  • Global Heparin Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......
  • Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......
  • Global Heparin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs